PhRMA Urges U.S. Trade Rep to Address Foreign Market Barriers

Drug Industry Daily
A A
PhRMA flagged market access barriers in Malaysia, Canada, Japan and South Korea in a submission to the U.S. Trade Representative (USTR).

To View This Article:

Login

Subscribe To Drug Industry Daily